Search Results - "Kirshenbaum, James M"

Comparison of the Use of Downstream Tests After Exercise Treadmill Testing by Cardiologists Versus Noncardiologists by Bittencourt, Marcio S., MD, MPH, Christman, Mitalee P., MD, Hulten, Edward, MD, MPH, Divakaran, Sanjay, MD, Skali, Hicham, MD, MSc, Kwong, Raymond Y., MD, MPH, Hainer, Jon, BS, Forman, Daniel E., MD, Kirshenbaum, James M., MD, Dorbala, Sharmila, MD, MPH, Di Carli, Marcelo F., MD, Blankstein, Ron, MD

“…Although exercise treadmill testing (ETT) is a useful initial test for patients with suspected cardiovascular (CV) disease, there is concern regarding the use…”
Get full text

Cardiac presentation of anaplastic large-cell lymphoma by Punnoose, Lynn R, Roh, Jason D, Hu, Stephanie, Udell, Jacob A, Wagle, Nikhil, Kirshenbaum, James M, Lacasce, Ann S

Get full text

A Dangerous Detour by Berg, David D, Kirshenbaum, James M, Gay, Elizabeth, Miller, Amy L, Loscalzo, Joseph

“…A 26-year-old woman with T-cell acute lymphoblastic leukemia and an indwelling port catheter presented with progressive dyspnea. She had received a diagnosis…”
Get full text

Myocardial Catastrophe: A Case of Sudden, Severe Myocardial Dysfunction by Hucker, William J, Chatzizisis, Yiannis S, Steigner, Michael L, Winters, Gayle L, Kirshenbaum, James M

Get full text

No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention by Resnic, Frederic S., Wainstein, Marco, Lee, Michael K.Y., Behrendt, Dominik, Wainstein, Rodrigo V., Ohno-Machado, Lucila, Kirshenbaum, James M., Rogers, Campbell D.K., Popma, Jeffrey J., Piana, Robert

“…Background No-reflow occurring during percutaneous coronary intervention (PCI) has been associated with poor inhospital outcomes. The objectives of this…”
Get full text

Catheter-directed thrombolysis for giant right atrial thrombus by Maron, Bradley A, Goldhaber, Samuel Z, Sturzu, Anthony C, Rhee, David K, Ali, Bilal S, Shah, Pinak Bipin, Kirshenbaum, James M

Get full text

Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI) 4 trial by Cannon, Christopher P, McCabe, Carolyn H, Diver, Daniel J, Herson, Steve, Greene, Robert M, Shah, Prediman K, Sequeira, Raphael F, Leya, Ferdinand, Kirshenbaum, James M, Magorien, Raymond D, Palmeri, Sebastian T, Davis, Vicki, Gibson, C.Michael, Poole, W.Kenneth, Braunwald, Eugene

“…Objectives. The aim of our study was to determine a superior tbrombolytic regimen from three: anistreplase (APSAC), frontloaded recombinant tissue-type…”
Get full text

MASSIVE PULMONARY EMBOLISM COMPLICATED BY RIGHT HEART FAILURE MANAGED WITH INTRAVASCULAR ULTRASOUND GUIDED PERCUTANEOUS THROMBECTOMY AND RVAD by Bertot, John H., Marcusa, Dan, Patel, Parth, Gross, David, Kirshenbaum, James M., Sabatine, Marc Steven, Kochar, Ajar

Get full text

Under Pressure by DeFilippis, Ersilia M, Vaidya, Anand, Ramani, Subha, French, Christopher, Kirshenbaum, James M

“…This interactive feature presents the case of a 61-year-old man with shortness of breath and cough. Test your diagnostic and therapeutic skills at NEJM.org. A…”
Get full text

Under Pressure by DeFilippis, Ersilia M., Vaidya, Anand, Ramani, Subha, French, Christopher, Kirshenbaum, James M.

Get full text

Under Pressure by DeFilippis, Ersilia M, Vaidya, Anand, Ramani Subha, French, Christopher, Kirshenbaum, James M

“…This interactive feature presents the case of a 61-year-old man with shortness of breath and cough. Test your diagnostic and therapeutic skills at NEJM.org…”
Get full text

Under Pressure by DeFilippis, Ersilia M, Vaidya, Anand, Ramani, Subha, French, Christopher, Kirshenbaum, James M

Get full text

Effect of large oral doses of ascorbic acid on uric acid excretion by normal subjects by Mitch, W E, Johnson, M W, Kirshenbaum, J M, Lopez, R E

“…The effects of large and oral doses of ascorbic acid on renal clearance and excretion of uric acid were studied in nongouty subjects because ascorbic acid has…”
Get more information

Under Pressure by DeFilippis, Ersilia M, Vaidya, Anand, Ramani, Subha, French, Christopher, Kirshenbaum, James M

Get full text

A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban by Simon, Daniel I., Liu, Christopher B., Ganz, Peter, Kirshenbaum, James M., Piana, Robert N., Rogers MD, Campbell, Selwyn MD, Andrew P., Popma, Jeffrey J.

“…Platelet inhibition is central to the efficacy of glycoprotein (GP) IIb‐IIIa antagonist therapy, but is not routinely measured during percutaneous coronary…”
Get full text

Prinzmetal's angina by Delacretaz, E, Kirshenbaum, J M, Friedman, P L

Get full text

A comparative study of light transmission aggregometry and automated bedside Platelet Function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban. Commentary by SIMON, Daniel I, LIU, Christopher B, HERRMANN, Howard C, GANZ, Peter, KIRSHENBAUM, James M, PIANA, Robert N, ROGERS, Campbell, SELWYN, Andrew P, POPMA, Jeffrey J, SWIERKOSZ, Tomasz A, VALETTAS, Nicholas

Get full text

A New Tc-99m-Labeled Myocardial Imaging Agent, Hexakis(t-Butylisonitrile)-Technetium(I) [Tc-99m TBI]: Initial Experience in the Human by Holman, B. Leonard, Jones, Alun G, Lister-James, John, Davison, Alan, Abrams, Michael J, Kirshenbaum, James M, Tumeh, Sabah S, English, Robert J

“…The cationic complex Tc-99m hexakis(t-butylisonitrile)technetium(I) (TBI) has been shown to concentrate in the myocardial tissue of several animal species. In…”
Get full text

Clot-selective coronary thrombolysis with lowdose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator by Kirshenbaum, James M., Bahr, Raymond D., Flaherty, John T., Gurewich, Victor, Levine, Herbert J., Loscalzo, Joseph, Schumacher, Richard R., Topol, Eric J., Wahr, Dennis W., Braunwald, Eugene

“…The effect of simultaneous infusions of low-dose recombinant tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator…”
Get full text

Nonthrombolytic intervention in acute myocardial infarction by Kirshenbaum, James M.

“…Alternative interventions are available for patients in whom thrombolytic therapy is inappropriate after an acute myocardial infarction. Administration of a β…”
Get full text